7 October 2024 (Lima, Peru) – New data from the PURPOSE 2 study of twice-yearly lenacapavir for HIV prevention are among the scientific highlights at HIVR4P 2024, the 5th HIV Research for Prevention ...

Namatai Kwekweza said she remained committed to her advocacy for change in Africa, despite a harrowing experience in Zimbabwe ...

Ireland based pharmaceutical company Gilead Sciences has said it will grant licences to six generic manufacturers to produce low cost lenacapavir, which has shown unprecedented efficacy at preventing ...

GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...

The company is committing to make at least 2 million doses of its long-acting PrEP therapy available in low- and middle-income countries next year and in 2026.

Highlanders FC is the oldest and most supported Football club in Zimbabwe. To the Highlanders faithful the team is a way of ...

ViiV’s strategy for CAB LA for PrEP in L&MICs is to maximise rapid access and uptake for populations with highest unmet needs ...

Kazakhstan's Ministry of Healthcare is intensifying its control over the epidemiological situation following the World Health ...

Controversial Zim dancehall artist Jimmy “Silent Killer” Mudereri faced a tumultuous scene this Sunday morning at ...

In five years’ time, the mental health treatment landscape will look radically different. We need funding to keep up with ...

Brenton Zinyama (18) said he found Mangeya’s project a useful tool in driving away youths from drugs. “Volleyball is fun. I ...

Gilead Sciences has announced a significant initiative aimed at enhancing access to its innovative HIV prevention drug, ...